Effect of Cilostazol on Preventing Paclitaxel ‐Induced Neuropathy in Patients with Breast Cancer: A Randomized Controlled Trial
ConclusionAdjunctive use of cilostazol may be considered as a novel option that might reduce the incidence of paclitaxel-induced peripheral neuropathy and improve the patients ’ QoL. Future larger clinical trials are warranted to confirm these findings.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Esraa A. Haroun,
Noha O. Mansour,
Ahmed Eltantawy,
Mohamed E. E. Shams Tags: RESEARCH ARTICLE Source Type: research
More News: Brain | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Cilostazol | Clinical Trials | Drugs & Pharmacology | Neurology | Peripheral Neuropathy | Study